Fundraising FoxRising Tide — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Armory provides continuous deployment software that helps development teams automate and manage application releases across their infrastructure at scale, with built-in safety and security controls.
Data & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US
Isaac Mosquera(CTO)inBen Mappen(Chief Customer Officer)inDaniel R. Odio(Founder)Lonne Jaffe(Director)Phil Boyer(Director)Rashmi Gopinath(Director)
Co-investorsBase Venture Management, Inc.Crosslink CapitalGaingelsInsight PartnersJavelin Venture PartnersLumia Capital+26 more
__Twitter.png)
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundKeshif VenturesAlexandriaArgonautic Ventures+2 more
PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings.
BiotechHealthtechMedical DevicesSilicon Valley, US
Julia Rasooly(CEO)in
Co-investorsCota CapitalGeekdomStartXTransPacific Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.